Skip to main content
Premium Trial:

Request an Annual Quote

Pharmacopeia Licenses Technology to Fqubed

NEW YORK, April 12 (GenomeWeb News) - Fqubed said today that it has received from Pharmacopeia a worldwide exclusive license to intellectual property related to multiplexed fluid dispensing through a novel valveless delivery system, fluid processing, and automated soft materials product collection.


Fqubed said that it has also licensed from Pharmacopeia two high-throughput experimentation instruments related to the technology. The company added that the technology was invented to streamline a solvent processing step in Pharmacopeia's discovery chemistry workflow, but that new application possibilities have been identified.


Details of how Fqubed plans to use the licensed technology were not disclosed.


Under the deal, Pharmacopeia is to receive an upfront fee and royalties on product sales.


The Scan

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."